Donated liposuction stem cells can assist in healing difficult wounds, it’s revealed
Cosmetic surgery is responsible for many positive things, but not many know about the simple stem cell therapies which are finally making their way towards the clinic. This new treatment for wounds caused by Crohn’s disease may well be the very first ‘off-the-shelf’ therapy to achieve European Union approval.
Wounds that are hard to treat such as those near the anus affect as many as 50,000 people in Europe annually. But now, in a phase III trial, a treatment advanced by Belgium-based experts TiGenix have developed the chances of healing such wounds by a significant 50%, and what’s more, there are said to be no adverse side effects.
The therapy takes advantage of the stem cells that have been derived from donated Liposuction tissue, which present extremely low levels of the proteins that set off immune reactions. As a result, the treatment, if approved after the publication of the full results in 2016, can be given off-the-shelf. Just to get an idea of how helpful this treatment could be, the stem cells from just one person could be used to treat up to 2,500 people.